In:
Journal of Law, Medicine & Ethics, Cambridge University Press (CUP), Vol. 25, No. 4 ( 1997), p. 234-242
Abstract:
Prostate cancer has become a major health concern of male Americans. It is now the most common nondermatologic cancer and the second leading cause of cancer death among men. The incidence of detected prostate cancer rose rapidly in recent years, partly because of prostate-specific antigen (PSA) testing; it is only now tapering off. Screening for prostate cancer with PSA is widespread in the United States, yet controversial: the American Urological Association recommends PSA screening and the American Cancer Society recommends offering screening; however, the United States Preventive Services Task Force (USPSTF) and the American College of Physicians (ACP) recommend against routine screening; and the American Academy of Family Physicians believes that the decision to screen should be left to the patient.
Type of Medium:
Online Resource
ISSN:
1073-1105
,
1748-720X
DOI:
10.1111/j.1748-720X.1997.tb01405.x
Language:
English
Publisher:
Cambridge University Press (CUP)
Publication Date:
1997
detail.hit.zdb_id:
2052584-9
SSG:
2
Bookmarklink